In August 2005, Lincoln Tecnologies was acquired by Phase Forward Inc (NASDAQ PFWD). With facilities also in Europe, Lincoln Technologies is a software development and consulting company that specializes in technologies for drug development and risk management. Lincoln's products serve business areas that are increasingly widely recognized as key areas of pharmaceutical industry investment: Strategic Pharmacovigilance, Applied Data Standards, and Clinical Trials Signal Detection. Lincoln's suite of industry-leading products and services is based on a common technology framework. Product offerings range from applications for detecting potential safety issues in clinical trials through signal detection algorithms that support postmarketing safety signal detection. Service offerings include clinical and safety data conversions, custom systems development, and strategic consulting on clinical research information systems Products are in use at commercial pharmaceutical and biotech companies in the US, Europe and Japan as well as at regulatory agencies throughout the world.
